Ardelyx (ARDX) Metrics: History & Chart

Ardelyx, Inc.(ARDX)

Biotechnology · Waltham, MA

$3.29-0.10 (-2.95%)

Delayed quote: Oct 6, 2026, 10:10 AM EDT

About Ardelyx, Inc.

Ardelyx, Inc. is a biopharmaceutical firm dedicated to the discovery, development, and commercialization of innovative medicines. The company primarily focuses on addressing gastrointestinal (GI) and cardiorenal conditions, serving patients both domestically in the United States and across international markets. Its flagship product candidate is tenapanor. This drug has successfully completed Phase III clinical trials for treating irritable bowel syndrome with constipation (IBS-C) and is also currently in Phase III development to manage hyperphosphatemia (high serum phosphorus) in adult patients with chronic kidney disease (CKD) who are undergoing dialysis. Ardelyx is also advancing other key pipeline assets, including RDX013, a potassium secretagogue designed to combat hyperkalemia (elevated serum potassium), a significant issue for individuals with compromised kidney and/or heart function. Furthermore, the company is in the early stages of developing RDX020, which targets metabolic acidosis, a serious electrolyte disorder frequently seen in CKD patients. To broaden the reach of tenapanor, Ardelyx has established strategic partnerships with Kyowa Kirin in Japan, Fosun Pharmaceutical Industrial Development Co. Ltd. in China, and Knight Therapeutics, Inc. in Canada, granting them rights for the drug's development and commercialization in their respective regions. Originally incorporated in 2007 as Nteryx, Inc., the company adopted its current name, Ardelyx, Inc., in June 2008. Its headquarters are located in Waltham, Massachusetts.

Waltham, MA

489 employees

www.ardelyx.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Michael G. Raab

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	-0.59%
30D Total Return	-10.32%
YTD Total Return	-41.85%
1Y Total Return	-35.55%
3Y Total Return	-16.09%
5Y Total Return	+158.80%
10Y Total Return	-1.98%
15Y Total Return	N/A
20Y Total Return	N/A

2026	-41.85%
2025	+14.99%
2024	-18.23%
2023	+117.54%
2022	+159.09%
2021	-32.10%
2020

CAGR TTM	-35.42%
CAGR 3Y	-5.68%
CAGR 5Y	+20.95%
CAGR 10Y	-0.20%
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	189.54
PE Ratio Avg TTM	197.34
PE Ratio Avg 3Y	197.34
Current VS TTM Avg	-3.95%
Current VS 3Y Avg	-3.95%
Current VS 5Y Avg	-3.95%

All Metrics

ARDX Valuation Metrics

ARDX Stock Price Metrics

ARDX Dividend Metrics

ARDX Growth Rate Metrics

ARDX Discounted Cash Flow Metrics

ARDX Returns By Period

ARDX Yearly Returns

ARDX Average Annual Returns By Period (CAGR)

ARDX Revenue Metrics

ARDX PE Ratio Metrics

ARDX PS Ratio Metrics

ARDX PB Ratio Metrics

ARDX Price to Free Cash Flow Ratio Metrics

ARDX Debt to Equity Ratio Metrics

ARDX PEG Ratio Metrics

ARDX FCF Yield

ARDX Earnings Yield

ARDX EBITDA Yield

ARDX OCF Yield

ARDX EV/EBIT Ratio Metrics

ARDX EV/EBITDA Ratio Metrics

ARDX EV/Assets Ratio Metrics

ARDX EV/Sales Ratio Metrics

ARDX Current Ratio Metrics

ARDX Quick Ratio Metrics

ARDX ROIC Metrics

ARDX Return on Assets Metrics

ARDX Return on Equity Metrics

ARDX Net Profit Margin Metrics

ARDX Gross Profit Margin Metrics

ARDX Tax Rate Metrics

PS Ratio	1.87
PS Ratio Avg TTM	3.40
PS Ratio Avg 3Y	5.27
Current VS TTM Avg	-44.93%
Current VS 3Y Avg	-64.53%
Current VS 5Y Avg	-78.44%

PB Ratio	5.64
PB Ratio Avg TTM	9.11
PB Ratio Avg 3Y	8.68
Current VS TTM Avg	-38.09%
Current VS 3Y Avg	-35.03%
Current VS 5Y Avg	-17.37%

PFCF Ratio	24.30
PFCF Ratio Avg TTM	7.50
PFCF Ratio Avg 3Y	8.93
Current VS TTM Avg	+223.99%
Current VS 3Y Avg	+172.13%
Current VS 5Y Avg	+172.13%

Debt/Equity Ratio	1.72
Debt/Equity Ratio Avg TTM	1.44
Debt/Equity Ratio Avg 3Y	0.93
Current VS TTM Avg	+19.15%
Current VS 3Y Avg	+85.74%
Current VS 5Y Avg	+118.69%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	4.11%
FCF Yield Avg TTM	24.40%
FCF Yield Avg 3Y	22.30%
Current VS TTM Avg	-83.16%
Current VS 3Y Avg	-81.57%
Current VS 5Y Avg	-81.57%

Earnings Yield	0.53%
Earnings Yield Avg TTM	0.51%
Earnings Yield Avg 3Y	0.51%
Current VS TTM Avg	+3.77%
Current VS 3Y Avg	+3.77%
Current VS 5Y Avg	+3.77%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	10.37
Ev/Ebit Ratio Avg TTM	9.35
Ev/Ebit Ratio Avg 3Y	9.35
Current VS TTM Avg	+10.86%
Current VS 3Y Avg	+10.86%
Current VS 5Y Avg	+10.86%

Ev/Ebitda Ratio	8.85
Ev/Ebitda Ratio Avg TTM	7.99
Ev/Ebitda Ratio Avg 3Y	7.99
Current VS TTM Avg	+10.79%
Current VS 3Y Avg	+10.79%
Current VS 5Y Avg	+10.79%

Ev/Assets Ratio	1.74
Ev/Assets Ratio Avg TTM	3.21
Ev/Assets Ratio Avg 3Y	3.50
Current VS TTM Avg	-45.81%
Current VS 3Y Avg	-50.29%
Current VS 5Y Avg	-40.80%

Ev/Sales Ratio	2.22
Ev/Sales Ratio Avg TTM	3.76
Ev/Sales Ratio Avg 3Y	5.58
Current VS TTM Avg	-40.90%
Current VS 3Y Avg	-60.21%
Current VS 5Y Avg	-73.80%

Current Ratio	3.34
Current Ratio Avg TTM	3.97
Current Ratio Avg 3Y	4.20
Current VS TTM Avg	-15.84%
Current VS 3Y Avg	-20.45%
Current VS 5Y Avg	-5.67%

Quick Ratio	3.15
Quick Ratio Avg TTM	3.74
Quick Ratio Avg 3Y	3.97
Current VS TTM Avg	-15.77%
Current VS 3Y Avg	-20.71%
Current VS 5Y Avg	-7.19%

ROIC	(7.99%)
ROIC Avg 3Y	(15.06%)
ROIC Avg 5Y	(43.35%)
Current VS 3Y Avg	+46.94%
Current VS 5Y Avg	+81.57%
Current VS 10Y Avg	+83.03%

ROA	(9.67%)
ROA Avg TTM	(2.95%)
ROA Avg 3Y	(4.00%)
Current VS TTM Avg	-228.35%
Current VS 3Y Avg	-142.03%
Current VS 5Y Avg	-7.81%

ROE	(37.38%)
ROE Avg TTM	(38.08%)
ROE Avg 3Y	(40.57%)
Current VS TTM Avg	+1.84%
Current VS 3Y Avg	+7.86%
Current VS 5Y Avg	+43.52%

Net Profit Margin	(12.35%)
Net Profit Margin Avg TTM	(14.88%)
Net Profit Margin Avg 3Y	(27.35%)
Current VS TTM Avg	+16.98%
Current VS 3Y Avg	+54.84%
Current VS 5Y Avg	+89.97%

Gross Profit Margin	93.96%
Gross Pft Margin Avg TTM	92.59%
Gross Pft Margin Avg 3Y	87.67%
Current VS TTM Avg	+1.48%
Current VS 3Y Avg	+7.18%
Current VS 5Y Avg	+4.92%

Tax Rate	0.75%
Tax Rate Avg 3Y	1.23%
Tax Rate Avg 5Y	1.23%
Current VS 3Y Avg	-38.98%
Current VS 5Y Avg	-38.98%
Current VS 10Y Avg	-73.51%